CN105230612B - Chlorpyrifos composite microsphere - Google Patents

Chlorpyrifos composite microsphere Download PDF

Info

Publication number
CN105230612B
CN105230612B CN201510470245.5A CN201510470245A CN105230612B CN 105230612 B CN105230612 B CN 105230612B CN 201510470245 A CN201510470245 A CN 201510470245A CN 105230612 B CN105230612 B CN 105230612B
Authority
CN
China
Prior art keywords
humic acid
chlopyrifos
sodium alginate
microsphere
complex microsphere
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201510470245.5A
Other languages
Chinese (zh)
Other versions
CN105230612A (en
Inventor
周新华
林粤顺
周红军
龚圣
徐华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhongkai University of Agriculture and Engineering
Original Assignee
Zhongkai University of Agriculture and Engineering
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhongkai University of Agriculture and Engineering filed Critical Zhongkai University of Agriculture and Engineering
Priority to CN201510470245.5A priority Critical patent/CN105230612B/en
Publication of CN105230612A publication Critical patent/CN105230612A/en
Application granted granted Critical
Publication of CN105230612B publication Critical patent/CN105230612B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Manufacturing Of Micro-Capsules (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention discloses a chlorpyrifos composite microsphere. The composite microsphere is prepared by taking humic acid modified sodium alginate as a composite matrix material to load chlorpyrifos and calcium chloride (CaCl)2) Prepared as a cross-linking agent. The invention forms a novel composite matrix material by mixing humic acid and sodium alginate. The interaction of humic acid and sodium alginate is utilized to improve the microsphere structure, so that the composite microsphere network structure becomes dense, the microsphere skeleton density is increased, the drug amount capable of being carried is increased, and the drug embedding capacity is enhanced, thereby improving the drug loading performance of the microsphere. Humic acid can also be used as a nutrient component of plants, so that the composite microspheres have the function of integrating pesticide and fertilizer.

Description

A kind of chlopyrifos complex microsphere
Technical field
The invention belongs to the technical field of composite, more particularly, to a kind of chlopyrifos complex microsphere.
Background technology
Chlopyrifos is the maximum kind of sales volume in insecticide in the world at present, its as the insecticide being widely used, With it is efficient the advantages of, prevention effect is excellent, has wide market prospects.But it has, and toxicity is higher, peculiar smell is larger lacks Point.
Microballoon is using natural or artificial synthesized high polymer material, and the medicine of the inside parcel is solid or liquid, shape Into load medicinal gel microballoon.In field of biological pesticide, because many agricultural chemicals have no idea directly to use, or it is directly used Effect it is bad, if it is desired that the effect of agricultural chemicals reaches best, it is necessary to strengthen the system, one of which by other approach Exactly using high polymer material come embedding medicinal, so that drug bearing microsphere be made.This high polymer material is down to the toxicity of medicine It is minimum, and agricultural chemicals is fully utilized.The effect of so allowing for medicine is with regard to that can reach most strong best.The best load of performance at present Medicine microballoon should possess following performance:(1)Biodegradability and nontoxicity;(2)Targeting;(3)Insoluble drug release controllability;(4) Hydrophily and(5)Good biocompatibility.
Sodium alginate is the sodium salt of alginic acid, have alginic acid gelling properties, Gelation Conditions are gentle, to pH value, temperature, Ionic strength has certain response, is the good material for making intelligent aqueous gel.The hydrogel of making is nontoxic to body, has good Good biocompatibility and can biology solution property, non-immunogenicity, thus be excellent drug carrier material.With sodium alginate by poison Dead tick embedding gets up to form gel micro-ball, can solve chlopyrifos very well and see the problems such as light decomposes, toxicity is higher, peculiar smell is larger. But sodium alginate hydrophily is strong, gel aperture is big, low to hydrophobic drug drugloading rate, and drug release rate is fast, and prominent release easily occurs. In addition, sodium alginate gel microsphere bad mechanical property, microsphere surface easily caves inward in manufacture or drying process, degradable Drug carrying ability is caused to decline with a large amount of swellings of water are met, and sodium alginate gel contains substantial amounts of hydrophilic radical, to organic The load capacity of medicine is not high.In order to expand application of the sodium alginate in terms of drug carrier material, it is necessary to be carried out to sodium alginate It is modified, to lift drugloading rate and envelop rate of the drug carrier material to medicine, and improve its Release Performance, to reach sustained release and control The effect released.
The content of the invention
The technical problems to be solved by the invention are the defects of overcoming existing sodium alginate cladding chlopyrifos to exist and technology Deficiency, chlopyrifos is loaded using humic acid modified sodium alginate as compound matrix material, there is provided a kind of humic acid/sodium alginate/ Chlopyrifos complex microsphere, drug carrying ability of the sodium alginate to chlopyrifos can be improved.Meanwhile humic acid is also used as the battalion of plant Form point, make the complex microsphere that there is the function of medicine fertilizer integration.
It is an object of the invention to provide a kind of humic acid/sodium alginate/chlopyrifos complex microsphere.
Another object of the present invention is to provide the preparation method of above-mentioned complex microsphere.
Above-mentioned purpose of the present invention is to be achieved by the following technical programs:
A kind of chlopyrifos complex microsphere, it is load chlopyrifos using humic acid modified sodium alginate as compound matrix material, With CaCl2Gained is prepared as crosslinking agent.
Humic acid is polycationic compounds, when being combined with anionic polymer sodium alginate, the carboxyl of its strand with The hydroxyl of sodium alginate can attract to form plural gel by positive and negative charge.Humic acid not only have carrier possessed by filling, The effects such as scattered, dilution, absorption, but also there is bioactivity, the stability of agricultural chemicals can be improved, and reduce agricultural chemicals in soil Loss.Therefore, the drug carrying ability of gel micro-ball system can be improved using humic acid.Due to the phase of humic acid and sodium alginate Interaction makes complex microsphere network structure become close, and during micro-sphere crosslinked, it is molten that chlopyrifos from matrix penetrates into crosslinking agent Liquid medium-rate is slower, therefore increase tendency is presented in drugloading rate, and the ability of embedding medicinal also accordingly increases.Further, since humic acid With colloidal property, larger specific surface area and abundant microcellular structure, therefore also there is preferable suction-operated, it can be poison Dead tick is preferably supported on carrier, so as to reduce the loss of chlopyrifos.
Meanwhile humic acid has multi-functional group, make it possess good ion-exchange performance and complexing with it is sequestering Can, cotton-shaped gel can be formed with crosslinking agent, crosslink density can be increased, improves micro-sphere structure, improves drug carrying ability.
Inventor also found, the ratio of humic acid and sodium alginate has shadow to properties such as the drugloading rate of microballoon, envelop rates Ring.
Preferably, in the chlopyrifos complex microsphere, the mass ratio of humic acid and sodium alginate is 10 ~ 60%.
It is highly preferred that in the complex microsphere, the mass ratio of humic acid and sodium alginate is 40%.On this condition, can obtain Obtain more preferably drugloading rate, envelop rate.
Preferably, in the complex microsphere, crosslinking agent CaCl2Quality and humic acid and sodium alginate gross mass quality Than for 4 ~ 14:1.
Preferably, by CaCl2It is prepared into CaCl2Solution, then mixed with humic acid and sodium alginate.
The preparation method of the chlopyrifos complex microsphere, it may be referred to the existing method for preparing complex microsphere.According to need The amount wanted, it can select to note drop method(Laboratory scale)Or spray drying(Industrial production)The methods of be prepared.
As a kind of exemplary preparation method, above-mentioned chlopyrifos complex microsphere can be prepared in accordance with the following steps:
S1. the mass ratio for determining humic acid and sodium alginate is 10 ~ 60%, and humic acid is added in alkaline solution, is stirred Fully dissolving, obtains humic acid solution;
S2. chlopyrifos is dissolved in anhydrous alcohol solution, be sufficiently mixed with the humic acid solution obtained by S1;
S3. in humic acid sodium alginate being slowly added into obtained by S2/chlopyrifos mixed liquor, continue stirring until and dissolved Entirely, bubble removing, obtain that colloidal sol is blended;
S4. blending colloidal sol is added to CaCl20.5 ~ 1.5h balling-up is crosslinked in solution, through being dried under vacuum to perseverance after cleaning Weight, produces humic acid/sodium alginate/chlopyrifos complex microsphere.
Preferably, alkaline solution described in step S1 is sodium hydroxide, potassium hydroxide, calcium hydroxide, sodium carbonate or bicarbonate One kind in sodium.
It is highly preferred that alkaline solution described in step S1 is sodium hydroxide.
It is highly preferred that humic acid described in step S1 is 40% with sodium alginate mass ratio.
Preferably, alcohols described in step S2 is one kind in methanol, ethanol, normal propyl alcohol or n-butanol.
It is highly preferred that alcohols described in step S2 is ethanol.
Certain density humic acid/sodium alginate/chlopyrifos blending colloidal sol is added to CaCl by the present invention2Cross-linking agent solution In, Ca2+Sodium alginate drop is entered by osmosis, the rapid crosslinking curing of drop forms gel micro-ball.Due to sodium alginate And CaCl2Reaction is crosslinked, forms IPN cross-linked network, makes the complex microsphere base material that there is stable structure.Inventor It has also been found that CaCl2The concentration of solution has an impact to the swelling ratio of complex microsphere.Work as CaCl2When solution concentration is higher, colloidal sol is blended Sodium ion and the calcium ion-exchanged rate in solution are high in liquid, the crosslinking degree increase of gel, the calcium alginate being complexed by calcium ion Gel structure tends to close, and the skeletal density of microballoon is big, causes hydrone to enter the resistance increase of microballoon, and swelling ratio reduces.It is multiple The swelling ratio of conjunction microballoon is lower, and the structure of complex microsphere is more stable, has more preferable slow release effect.Preferably, described in step S4 CaCl2Solution concentration is 0.3 ~ 1.0mol/L.
It is highly preferred that CaCl described in step S42Solution concentration is 0.9mol/L.
Inventor also found that crosslinking time length also has a certain impact to the swelling ratio of complex microsphere.Preferably, step Crosslinking time described in S4 is 0.5 ~ 1.5h.
It is highly preferred that crosslinking time described in step S4 is 1h.
Compared with prior art, the invention has the advantages that:
The present invention loads chlopyrifos using humic acid modified sodium alginate as compound matrix material, there is provided and a kind of humic acid/ Sodium alginate/chlopyrifos complex microsphere, drug carrying ability of the sodium alginate to chlopyrifos can be improved, is had the advantage that:
1. the interaction of humic acid and sodium alginate improves micro-sphere structure, complex microsphere network structure is set to become close Collection, the skeletal density of microballoon is big, and the medication amount that can be carried is more, also enhances the ability of embedding medicinal, so as to improve microballoon Drug carrying ability;Humic acid has colloidal property, larger specific surface area and more rich microcellular structure, has preferably absorption to make With it preferably can be maintained at chlopyrifos on carrier, so as to reduce the loss of chlopyrifos.Humic acid is also used as plant Nutritional ingredient, make the complex microsphere have medicine fertilizer integration function.And humic acid contains substantial amounts of functional group, has Good ion-exchange performance and complexing and chelating ability, itself and CaCl2Mixing, the crosslink density of micro-sphere structure can be increased, So as to improve the drug carrying ability of microballoon.
2. sodium alginate and CaCl2Reaction is crosslinked, forms IPN cross-linked network, calcium alginate gel structure is become To close, the skeletal density of microballoon is big, causes hydrone to enter the resistance increase of microballoon, makes the reduction of complex microsphere swelling ratio, tool There is stable structure.
3. it is 40% to work as humic acid with sodium alginate mass ratio, crosslinking agent CaCl2Concentration is 0.9mol/L, and crosslinking time is During 1h, the cross-linked scaffold density of complex microsphere reaches saturation, and drugloading rate and envelop rate reach peak value.
Brief description of the drawings
Fig. 1 is chlopyrifos(a), humic acid/sodium alginate micro ball(b), humic acid/sodium alginate/chlopyrifos microballoon(c)'s FT-IR spectrograms.
Fig. 2 is humic acid/sodium alginate/chlopyrifos microballoon(a), sodium alginate/chlopyrifos microballoon(b), chlopyrifos(c)'s Differential scanning calorimetric curve.
Fig. 3 is influence of the mass ratio of humic acid and sodium alginate to chlopyrifos drugloading rate and envelop rate.
Fig. 4 is crosslinker concentration to the chlopyrifos drugloading rate of complex microsphere and the influence of envelop rate.
Fig. 5 is influence of the mass ratio of humic acid and sodium alginate to complex microsphere swelling ratio.
Embodiment
Present disclosure is further illustrated with reference to specific embodiment, but should not be construed as limiting the invention. Without departing from the spirit and substance of the case in the present invention, the simple modifications or substitutions made to the inventive method, step or condition, Belong to the scope of the present invention;Unless otherwise specified, technological means used in embodiment is well known to those skilled in the art Conventional meanses.
Unless stated otherwise, the reagent of the invention used, method and apparatus for the art conventional reagent, method and are set It is standby.Unless stated otherwise, agents useful for same and material of the present invention are purchased in market.
Embodiment 1-12 prepares humic acid/sodium alginate/chlopyrifos complex microsphere
By humic acid and the mass ratio of sodium alginate, the quality of fixed sodium alginate, the humic acid of different quality is distinguished It is dissolved in the mol/LNaOH aqueous solution of 20 mL 0.1, fully dissolving is heated under magnetic agitation;The g of precise 0.6 chlopyrifos It is dissolved in 5 mL absolute ethyl alcohol, is sufficiently mixed with humic acid solution;Precise 0.3g sodium alginates, are slowly added into rotten plant In acid/chlopyrifos blended liquid, stop heating, stop stirring after abundant dissolving, ultrasonic disperse bubble removing, obtain humic acid/sea Mosanom/chlopyrifos blending colloidal sol.The dropwise addition of fixed syringe pump is highly 30 cm, and rate of addition is 50 mLh-1, medical injection Device specification is 10 mL, and colloidal sol will be blended and be added dropwise to the CaCl that volume is 50mL2Balling-up is crosslinked in solution, vacuum is done after cleaning 3 times It is dry to constant weight, the humic acid/sodium alginate/chlopyrifos complex microsphere being prepared is listed in Table 1 below.
Table 1 prepares the complex microsphere of humic acid/sodium alginate/chlopyrifos
Comparative example 1 prepares sodium alginate/chlopyrifos microballoon
Precise 0.6g chlopyrifos heating is dissolved in 5ml absolute ethyl alcohol;Precise 0.3g sodium alginates, slowly It is added in chlopyrifos ethanol solution, stops heating, stops stirring after abundant dissolving, ultrasonic disperse bubble removing, obtain marine alga Sour sodium/chlopyrifos blending colloidal sol.The dropwise addition of fixed syringe pump is highly 30 cm, and rate of addition is 50 mLh-1, injector for medical purpose Specification is 10 mL, and it is the CaCl that 50mL concentration is 0.9mol/L that blending colloidal sol is added dropwise into volume21h balling-up is crosslinked in solution, Constant weight is dried under vacuum to after cleaning 3 times, produces sodium alginate/chlopyrifos microballoon.
Comparative example 2 prepares humic acid/sodium alginate micro ball
By humic acid and the mass ratio of sodium alginate, the quality of fixed sodium alginate, the humic acid of different quality is distinguished It is dissolved in the 20 mL 0.1mol/LNaOH aqueous solution, is fully dissolved under magnetic agitation;Precise 0.3g sodium alginates, slowly add Enter into humic acid solution, stop stirring after abundant dissolving, ultrasonic disperse bubble removing, obtain humic acid/sodium alginate blending Colloidal sol.The dropwise addition of fixed syringe pump is highly 30 cm, and rate of addition is 50 mLh-1, injector for medical purpose specification is 10 mL, by altogether It is the CaCl that 50mL concentration is 0.9mol/L that miscible glue, which is added dropwise to volume,21h balling-up is crosslinked in solution, is dried in vacuo after cleaning 3 times To constant weight, humic acid/sodium alginate micro ball is produced.
Structure is carried out to above-described embodiment, comparative example 1, comparative example 2 and chlopyrifos and performance is tested, it is as a result as follows:
The structural characterization of microballoon:
1st, FT-IR measure and analysis:Sodium alginate, humic acid and humic acid/sodium alginate/chlopyrifos complex microsphere crush Powder, through KBr tablettings, using Spectrum100 type Fourier infrared spectrographs(FT-IR infrared spectrum measurement, scanning) are carried out Wave-number range is 4000 ~ 500cm-1, scanning times 4 times.
Fig. 1 is chlopyrifos, humic acid/sodium alginate micro ball, the FT-IR of humic acid/sodium alginate/chlopyrifos complex microsphere Spectrogram.From Fig. 1 c as can be seen that 1549,1412,1170cm-1There is the characteristic absorption peak of chlopyrifos in place, is pyrrole respectively The C-C in C=C, aromatic series, aromatic P-O-C in pyridine ring, illustrate to have loaded chlopyrifos in complex microsphere.
2nd, means of differential scanning calorimetry (DSC) tracing analysis:Use DSC differential scanning calorimetries, temperature elevating range 20~250 DEG C, heating rate is 20 DEG C of min-1, nitrogen rate 30mL/min, it is compound micro- to determine humic acid/sodium alginate/chlopyrifos Ball, sodium alginate/chlopyrifos microballoon and the differential scanning calorimetric curve of chlopyrifos.
Fig. 2 is humic acid/sodium alginate/chlopyrifos complex microsphere(a), sodium alginate/chlopyrifos microballoon(b), chlopyrifos (c)Differential scanning calorimetric curve.Occur highly endothermic peak at 43.2 DEG C in curve c, be because of chlopyrifos at this temperature Fusing, this is consistent with the fusing point of chlopyrifos;Humic acid/sodium alginate/chlopyrifos complex microsphere occurs at 45.4 DEG C in curve a The melting peak of chlopyrifos;There is the melting peak of chlopyrifos at 41.8 DEG C in sodium alginate/chlopyrifos microballoon in curve b, shows poison Dead tick is still coated in microballoon with crystalline state.Compared with c, chlopyrifos melting peak is subjected to displacement by curve a, b, and this is due to poison with poison Tick forms active force with sodium alginate, the intermolecular of humic acid.
The measure of microballoon drugloading rate and envelop rate
1st, the assay method of drugloading rate:Quantitative 30mg microballoons are weighed, are transferred to 25mL volumetric flasks, add a certain amount of 40% Ethanol solution, it is subsequently placed in ultrasonic cleaner and is cleaned(Ultrasound destruction micro-sphere structure), then volumetric flask is positioned over perseverance In tepidarium oscillator, 24h is vibrated in 35 DEG C of waters bath with thermostatic control.Corresponding scale is finally settled to again, after being well mixed, takes upper strata clear Liquid dilutesxTimes, under λ=290nm wavelength, the absorbance of determination sample solution.
2nd, the assay method of envelop rate:Reference standard concentration curve draws the concentration of chlopyrifos solution, by formula (1) and (2) agricultural chemicals drugloading rate (LC) and envelop rate (EE) are calculated:
LC=carrying medicaments quality/microspheres quality (1)
Carrying medicament gross mass/total drug quality (2) in EE=microballoons
3rd, interpretation of result:
The drugloading rate and envelop rate of humic acid/sodium alginate/chlopyrifos complex microsphere are listed in Table 2 below.
The drugloading rate and envelop rate of the chlopyrifos complex microsphere of table 2
Influence of the mass ratio of different humic acids and sodium alginate to drugloading rate and envelop rate, as shown in figure 3 and table 2.Knot Fruit shows that, with the increase of humic acid and sodium alginate mass ratio, the trend of first increases and then decreases is presented in drugloading rate.When ratio is low When 40%, because the interaction of humic acid and sodium alginate makes complex microsphere network structure become close, microballoon had been crosslinked Cheng Zhong, it is slack-off that medicine from matrix penetrates into cross-linking agent solution medium-rate, therefore drugloading rate is presented increase tendency, and its embedding medicinal Ability also accordingly increases.When ratio reaches 40%, drugloading rate reaches peak value 59.52%, and envelop rate reaches peak value 51.42%.When than When example is higher than 40%, complex microsphere network structure becomes even closer, while complex microsphere can accommodate the space reduction of medicine, Therefore reduction trend is presented in drugloading rate and envelop rate.
Influence of the different crosslinker concentrations to drugloading rate and envelop rate, as shown in Fig. 4 and table 2.As a result show, with crosslinking The trend of increase is presented in the increase of agent concentration, drugloading rate and envelop rate.CaCl2When solution concentration is relatively low, sodium in sol solutionses is blended Ion is low with the calcium ion-exchanged rate in solution, and the three-dimensional netted gel structure of calcium alginate is more loose, and drugloading rate is low, embeds medicine Thing ability.And CaCl2When solution concentration is higher, sodium ion and the calcium ion-exchanged rate height in solution in sol solutionses is blended, it is micro- The skeletal density of ball is big, and the medication amount that can be carried increases, and also enhances its embedding medicinal ability.
Influence of the different crosslinking times to drugloading rate and envelop rate, as shown in table 2.With the increase of crosslinking time, medicine is carried The trend of first increases and then decreases is presented in amount and envelop rate.This is due to that crosslinking time is longer, and microspherulite diameter, which reduces, causes internal junction Structure is closer, and microchannel becomes narrow, so as to add hydrone into the resistance inside microballoon.It is micro- but crosslinking time is long Ball is immersed in the overlong time in water, can cause the swelling behavior of microballoon to increase, and microballoon internal structure is progressively evacuated, and microchannel increases Greatly, medicine is dissolved into external solution from microballoon again, so that drugloading rate declines, the ability of embedding medicinal also decreases.
Influence of the different mixing speeds to drugloading rate and envelop rate, as shown in table 2, with the increase of mixing speed, carry medicine The trend of first increases and then decreases is presented in amount and envelop rate.When low whipping speed is 500 r/min, cross-linking reaction is most abundant, carries medicine Amount and envelop rate reach highest.
Microspheres swell performance evaluation
Microspheres swell performance test methods:The dry microspheres of certain mass are weighed, are placed in medium solution to swelling equilibrium, Unnecessary liquid is filtered off, the moisture of microsphere surface is blotted with filter paper, is weighed, calculates swelling ratio (SR).Swelling ratio calculation formula (3) It is as follows:
In formula, WSFor quality (g) of the dry microspheres in water during swelling equilibrium;
WdFor the quality (g) of dry microspheres.
Table 3
From table 3 it can be seen that humic acid is added in sodium alginate micro ball, it is possible to reduce the swelling ratio of microballoon.Swelling ratio Smaller, complex microsphere can obtain more preferably slow release effect.From the foregoing, the addition of humic acid can also influence drugloading rate and encapsulating Rate, under conditions of embodiment 12, drugloading rate, envelop rate and swelling ratio can be made to obtain good balance.
The above embodiment of the present invention is only to clearly demonstrate example of the present invention, and is not the reality to the present invention Apply the restriction of mode.For those of ordinary skill in the field, can also make on the basis of the above description other Various forms of changes or variation.There is no necessity and possibility to exhaust all the enbodiments.All spirit in the present invention With all any modification, equivalent and improvement made within principle etc., it should be included in the protection domain of the claims in the present invention Within.

Claims (1)

1. a kind of chlopyrifos complex microsphere, it is characterised in that the complex microsphere is to be prepared via a method which to obtain:
By humic acid and the mass ratio 40% of sodium alginate, fixed sodium alginate 0.3g quality, humic acid is dissolved in 20 mL Fully dissolving is heated in the 0.1 mol/LNaOH aqueous solution, under magnetic agitation, mixing speed is 500 r/min;Precise 0.6 G chlopyrifos is dissolved in 5 mL absolute ethyl alcohol, is sufficiently mixed with humic acid solution;Precise 0.3g sodium alginates, slowly It is added in humic acid/chlopyrifos blended liquid, stops heating, stops stirring after abundant dissolving, ultrasonic disperse bubble removing, obtain Humic acid/sodium alginate/chlopyrifos blending colloidal sol;The dropwise addition of fixed syringe pump is highly 30 cm, and rate of addition is 50 mL h-1, injector for medical purpose specification is 10 mL, and colloidal sol will be blended and be added dropwise to the CaCl that volume is 50mL2Balling-up is crosslinked in solution, when CaCl2When solution concentration is 0.7 mol/L, crosslinking time is 0.5 hour or works as CaCl2When solution concentration is 0.7 mol/L, hand over It is 1 hour to join the time, is dried under vacuum to constant weight after cleaning 3 times, chlopyrifos complex microsphere is prepared.
CN201510470245.5A 2015-08-04 2015-08-04 Chlorpyrifos composite microsphere Active CN105230612B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510470245.5A CN105230612B (en) 2015-08-04 2015-08-04 Chlorpyrifos composite microsphere

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510470245.5A CN105230612B (en) 2015-08-04 2015-08-04 Chlorpyrifos composite microsphere

Publications (2)

Publication Number Publication Date
CN105230612A CN105230612A (en) 2016-01-13
CN105230612B true CN105230612B (en) 2018-03-06

Family

ID=55028682

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510470245.5A Active CN105230612B (en) 2015-08-04 2015-08-04 Chlorpyrifos composite microsphere

Country Status (1)

Country Link
CN (1) CN105230612B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108208354B (en) * 2018-01-18 2021-03-23 仲恺农业工程学院 Microspheres capable of slowly releasing calcium iodate and preparation method thereof
CN108812669A (en) * 2018-06-19 2018-11-16 西南大学 A kind of multilayer package carried medicine sustained-release hydrogel and preparation method thereof
CN110463700B (en) * 2019-07-26 2021-04-23 中国农业大学 Pendimethalin sustained release agent and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104434879B (en) * 2014-11-17 2017-12-15 黑龙江省兽医科学研究所 Chitosan sodium alginate medicine carrying microcapsule preparation method

Also Published As

Publication number Publication date
CN105230612A (en) 2016-01-13

Similar Documents

Publication Publication Date Title
Li et al. Characterization, swelling and slow-release properties of a new controlled release fertilizer based on wheat straw cellulose hydrogel
CN105230612B (en) Chlorpyrifos composite microsphere
CN110272314A (en) A method of preparing cladded type stalk fibre based water-holding slow-release fertilizer
CN104840430B (en) A kind of chlorogenic acid chitosan microball and its preparation process and application
CN102274192B (en) Carboxymethyl chitosan medicament-carrying microspheres and preparation method thereof
CN107011526B (en) Soybean protein isolate-sodium alginate plural gel pearl of multiple sensitivity and its preparation and application
CN106259320A (en) A kind of water-absorbing-retaining sustained-release pesticides and preparation method thereof
Mesias et al. Coated NPK fertilizer based on citric acid-crosslinked chitosan/alginate encapsulant
CN107517960A (en) A kind of microballoon suspension seed-coating agent and preparation method thereof
CN105153367A (en) Preparation method of dicyandiamide mesoporous surface molecularly imprinted polymer microspheres
CN110200936A (en) A kind of bioadhesive porous sustained-release microsphere and preparation method thereof
CN109287627A (en) A kind of solid dispersions matrix and its application
CN1326330A (en) Therapeutic use of polymers
Chen et al. Multifunctional Borax Cross-Linked Hydroxypropyl Guar Gum Hydrogels with Crop Nutritional Function as Carriers for Dual-Responsive Acaricide Release
CN103585113A (en) Apigenin polylactic acid sustained release microsphere and preparation method thereof
CN101438701A (en) Film-forming agent for seed-coating containing polyvinyl alcohol and oxidized starch-acrylamide copolymer
CN108948935A (en) A kind of preparation method and applications of film-forming agent for seed coating
CN113197200B (en) Preparation method and application of gel drug-loading system with pesticide molecule hymexazol as gelling agent
Zhang et al. In situ forming of PEG-NH2/dialdehyde starch Schiff-base hydrogels and their application in slow-release urea
CN109526952A (en) A kind of glycosylated pesticide nano micro-capsule and preparation method thereof
CN1290412C (en) Medicine composition for killing schistosome, and its prepn. method
CN103897203A (en) Method for preparing amphipathic nano microsphere composite network aquagel
CN105078924B (en) A kind of sodium alginate base pH response type drug microcapsules and preparation method thereof
CN107537038A (en) A kind of method for improving water soluble drug microballoon drug-loading system Yield of Mitoxantrone
CN107333759A (en) Light-operated sustained-release pesticides preparation and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant